PURPOSE 5

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

Lenacapavir InjectionOngoingActive not recruitingPhase 2Open NCT06513312 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…